| Heading: |
Estradiol: Shortages |
| Question ID: |
1797080 |
| UIN: |
48066 |
| House: |
Commons |
| Date tabled: |
2025-04-24 |
| Asking Member ID: |
5351 |
| Asking Member display name: |
Gregory Stafford
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Gregory Stafford
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of the availability of Estradot hormone replacement therapy patches; and what steps he is taking to ensure consistent supply for patients. |
| Is named day: |
true |
| Date of holding answer: |
|
| Date answered: |
2025-04-29 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
There are over 70 hormone replacement therapy (HRT) products, and the vast majority are in good supply. Previously there has been issues with the supply of a limited number of these products, primarily driven by very sharp increases in demand. Following t... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |